Combination of Immunosuppressive Agents in Treatment of Steroid-Resistant Minimal Change Disease and Primary Focal Segmental Glomerulosclerosis-Reference-Cited by-同舟云学术

Combination of Immunosuppressive Agents in Treatment of Steroid-Resistant Minimal Change Disease and Primary Focal Segmental Glomerulosclerosis

Published:2005-01 Issue:5 Volume:27 Page:523-530
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

El-Reshaid Kamel,El-Reshaid Wael,Madda John

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/08860220500198623

Reference38 articles.

1. U.S. Renal Data System, USRDS 1998 Annual Data Report; National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, April 1998; 23–35.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting;Pediatric Nephrology;2023-11-10

2. Rituximab/Mycophenolate Combination Therapy in Children with Calcineurin Inhibitor-Resistant FSGS;Indian Journal of Nephrology;2023-06-12

3. Steroid-resistant nephrotic syndrome in children: Clinicohistology and pattern of response to immunosuppressive;Paediatric Nephrology Journal of Bangladesh;2023

4. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome;Pediatric Nephrology;2020-05-07

5. Current understandings in treating children with steroid-resistant nephrotic syndrome;Pediatric Nephrology;2020-02-21